Oncology Institute Inc

Company Profile

Oncology Institute Inc had its IPO on 2021-11-15 under the ticker symbol TOI.

The company operates in the Healthcare sector and Medical Care Facilities industry. Oncology Institute Inc has a staff strength of 750 employees.

Stock update

Shares of Oncology Institute Inc opened at $1.63 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $1.45 - $1.68, and closed at $1.65.

This is a -0.6% slip from the previous day's closing price.

A total volume of 214,403 shares were traded at the close of the day’s session.

In the last one week, shares of Oncology Institute Inc have increased by +43.48%.

Oncology Institute Inc's Key Ratios

Oncology Institute Inc has a market cap of $83.90 million, indicating a price to book ratio of 0.6164 and a price to sales ratio of 0.2858.

In the last 12-months Oncology Institute Inc’s revenue was $292.82 million with a gross profit of $52.09 million and an EBITDA of $-58675000. The EBITDA ratio measures Oncology Institute Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Oncology Institute Inc’s operating margin was -21.72% while its return on assets stood at -18.94% with a return of equity of -58.05%.

In Q2, Oncology Institute Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 31.7%.

Oncology Institute Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-0.87 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Oncology Institute Inc’s profitability.

Oncology Institute Inc stock is trading at a EV to sales ratio of 0.4042 and a EV to EBITDA ratio of 21.0097. Its price to sales ratio in the trailing 12-months stood at 0.2858.

Oncology Institute Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$229.96 million

Total Liabilities

$33.51 million

Operating Cash Flow

$0

Capital Expenditure

$937000

Dividend Payout Ratio

0%

Oncology Institute Inc ended 2024 with $229.96 million in total assets and $0 in total liabilities. Its intangible assets were valued at $229.96 million while shareholder equity stood at $84.72 million.

Oncology Institute Inc ended 2024 with $0 in deferred long-term liabilities, $33.51 million in other current liabilities, 7000.00 in common stock, $-109977000.00 in retained earnings and $7.23 million in goodwill. Its cash balance stood at $28.89 million and cash and short-term investments were $39.18 million. The company’s total short-term debt was $6,001,000 while long-term debt stood at $83.69 million.

Oncology Institute Inc’s total current assets stands at $104.07 million while long-term investments were $58.94 million and short-term investments were $10.29 million. Its net receivables were $46.89 million compared to accounts payable of $13.12 million and inventory worth $12.17 million.

In 2024, Oncology Institute Inc's operating cash flow was $0 while its capital expenditure stood at $937000.

Comparatively, Oncology Institute Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$1.65

52-Week High

$5.47

52-Week Low

$0.33

Analyst Target Price

$4

Oncology Institute Inc stock is currently trading at $1.65 per share. It touched a 52-week high of $5.47 and a 52-week low of $5.47. Analysts tracking the stock have a 12-month average target price of $4.

Its 50-day moving average was $0.91 and 200-day moving average was $0.95 The short ratio stood at 0.98 indicating a short percent outstanding of 0%.

Around 1902.1% of the company’s stock are held by insiders while 5828.8% are held by institutions.